KIMBERLY CEASER: Open Payments
NPI 1689627457 · NAGS HEAD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 44 payments from 11 companies in 2025. Trend: 2023 $831 · 2024 $1,334 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $219 |
| Merck Sharp & Dohme LLC | 10 | $162 |
| Novo Nordisk Inc | 6 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Boston Scientific Corporation | 2 | $75 |
| Actelion Pharmaceuticals US, Inc. | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Amgen Inc. | 2 | $31 |
| PFIZER INC. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: FARXIGA, VERQUVO, Wegovy, JARDIANCE, WATCHMAN FLX, LEQVIO, OPSUMIT, REPATHA.
Industry payments across NC — which companies pay providers there.
